Stock data
Lisata Therapeutics, Inc. (LSTA)
Lisata Therapeutics, Inc. (LSTA) reported revenue of US$0.17M and net income of -US$16.59M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.17M | — | -US$18.21M | -US$16.59M | — |
| 2024 | US$1.00M | — | -US$22.41M | -US$19.98M | — |
| 2023 | US$0.00M | — | -US$25.71M | -US$20.84M | — |
| 2022 | US$0.00M | — | -US$57.60M | -US$54.23M | — |
| 2021 | — | — | -US$29.05M | -US$27.47M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$2.93M | — |
| 2026-03-31 | US$0.00M | -US$4.49M | — |
| 2025-12-31 | US$0.10M | -US$2.95M | — |
| 2025-09-30 | US$0.00M | -US$4.25M | — |
| 2025-06-30 | US$0.07M | -US$4.66M | — |
| 2025-03-31 | US$0.00M | -US$4.72M | — |
| 2024-12-31 | US$1.00M | -US$4.61M | — |
| 2024-09-30 | US$0.00M | -US$4.93M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.